MRI Prostate Cancer Detection
Prostate Cancer Detection:
What Should I know?
Many people believe that the PSA blood test can detect prostate cancer, but this is not true. The PSA test isn’t specifically designed to identify cancer. A higher-than-normal PSA level can signal various non-cancerous prostate conditions. As a result, additional information is necessary. Typically, urologists suggest an immediate ultrasound-guided needle biopsy (TRUS biopsy), which is an invasive procedure that carries risks like pain and infection. But why undergo such a procedure without confirming the presence of cancer or having a clear target location in the prostate?
If your PSA is elevated and your MRI is normal you may not need a biopsy.
BlueLaser™ 3T mp MRI: Better Early Detection
When a high PSA level raises concerns about cancer, the next step before performing a biopsy is to obtain an accurate 3D image of the prostate, distinguishing both healthy and cancerous tissue. It’s just as crucial to identify healthy tissue as it is to detect unhealthy areas. Ultrasound alone isn’t sufficient, as it can’t pinpoint the specific differences necessary to distinguish cancer from normal tissue.
Our BlueLaser™ 3T mpMRI Plus features the latest advancements in multiparametric imaging, including Restricted Spectrum Imaging (RSI) powered by AI, which takes cancer detection to a whole new level. Originally developed for brain imaging, RSI detects subtle differences in neurological diseases that were previously undetectable. When applied to prostate imaging, it makes potentially cancerous lesions stand out clearly.
Research now demonstrates that combining cutting-edge technology with expert knowledge makes a significant impact. By integrating the enhanced accuracy of AI-powered RSI with the pioneering expertise of Dr. Sperling and his team, the Sperling Prostate Center remains at the forefront of prostate cancer imaging.
If the BlueLaser™ 3T mpMRI eliminates the possibility of cancer, it provides reassurance and helps avoid unnecessary biopsies or further tests. However, if a suspicious area is found and a biopsy is required, we offer the advanced option of in-bore MRI-guided targeted biopsy.
Keep in mind: Early-stage prostate cancer typically shows no symptoms. Detecting it early leads to more accurate diagnoses, better treatment options, and improved outcomes.
PSA: What’s Normal, and What Does it Mean?
A higher-than-normal PSA can indicate noncancerous conditions such as aging-related enlargement, inflammation, or infection. Certain activities, such as riding a bike or having sex can trigger a temporary increase in PSA that has nothing to do with disease.
On the other hand, up to 15% of men with normal PSA levels can still have prostate cancer. Even when PSA levels are abnormal, as many as 75% of men end up not having prostate cancer yet have had unnecessary biopsies and worried for nothing.
Also, the Digital Rectal Exam (DRE) is not reliable for detecting prostate cancer. The doctor can only feel the surface of the gland closest to the rectal wall, completely missing small tumors located more deeply where most prostate cancer begins. It is neither thorough nor accurate.
Is BlueLaser™ 3T mp MRI Right for You?
Our BlueLaser™ 3T mpMRI empowers our patients by providing accurate knowledge about what’s going on in their bodies, both normal and disease. You should consider BlueLaser™ 3T mpMRI for the earliest possible detection if:
• You have an elevated or rising PSA
•You have an abnormal DRE
•You were treated for a prostate infection or inflammation but your PSA is still high
• You are on Active Surveillance
• You are in a high-risk category to develop prostate cancer (genetic or environmental factors)
• You have not had a PSA test but you have unusual urinary symptoms